Pericardial effusion and cardiac tamponade is a rarely reported complication following stem cell transplant (SCT). The incidence among pediatric SCT recipients is not well defined. To assess the ...

Randomized trial data on pericardial diseases are scarce, but a number of new studies are moving the management of these conditions from empirically-based to evidence-based medicine. Massimo ...

Pericardial effusion can develop into cardiac tamponade, which is a medical emergency. If you have symptoms such as chest pressure or pain, shortness of breath, and dizziness, go to the ER as soon ...

A 62-year-old woman was evaluated for recurrent hemorrhagic pericardial effusion. Fourteen years earlier, she had undergone transcatheter closure of an atrial septal defect. A diagnosis was made.

Pericardial devascularization was performed. Fifth, the omentum majus (10 × 5 cm and 10 × 10 cm) was excised and the retrosternal space was separated.

November 17, 2009 (Orlando, Florida) — The nonsteroidal anti-inflammatory drug (NSAID) diclofenac was not effective in reducing pericardial effusion in the POPE study. The study was presented ...

Background: Malignant pericardial effusion (MPE) is a relatively common complication of advanced malignancies including lung and breast cancer. Although pericardial drainage results in good palliation ...

Two hundred nineteen patients underwent pericardiocentesis during the study period. The effusion was cancer-related in 43.8% of cases. Median survival was 59.6 weeks (95% CI, 24.3 to 94.8 weeks).

News Release 3-Mar-2021 Pericardial injection effective, less invasive way to get regenerative therapies to heart Peer-Reviewed Publication North Carolina State University ...